science
AAPS PharmSci 360: CMC Strategies, Part 3

In a preview of their panel discussion at AAPS PharmSci 360 2026, Alfred Rumondor, PhD, AbbVie, and Swita Singh, PhD, Bristol Myers Squibb, discuss the implementation of risk-based approaches for CMC.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories

Mysterious oarfish's fins inspire large underwater robot design
Phys.org

How sea squirts perceive underwater noise
Phys.org

International study identifies key childhood experiences that predict happiness and well-being in adulthood
Phys.org

Women leave psychology research more often than men, especially early in their careers
Phys.org

Antarctica's ice loss is locked in, and extra snowfall won't save it—low‑lying coastal areas elsewhere to suffer
Phys.org